Category: Disease States

Disease States

WHOOP Adds Women’s Health Blood Biomarker Panel to Its Lab Testing Lineup

The new panel includes 11 female-specific biomarkers covering hormonal transitions, thyroid function, and nutrient levels.

Updated Guideline Issued on Lipid and Cholesterol Management, Expanding Role of Key Biomarker Tests
The Power of High-Sensitivity Troponin in Rapid Testing of Cardiovascular Disease
Precipio and Memorial Sloan-Kettering Publish Study on BCR::ABL1 Assay for Leukemia Monitoring
Antibody Test for Mpox Validated During Active Outbreak in Rwanda
WHO Recommends Near-Point-of-Care Molecular Tests, Tongue Swabs, and Sputum Pooling for Tuberculosis Diagnosis
Walgreens Partners to Expand Colorectal Cancer Screening Access
Hepion Pharmaceuticals Licenses ctRNA Biomarker Assay for Liver Cancer Detection
FDA Grants Breakthrough Device Designation to MeMed’s Capillary Blood Infection Test
Protein Biomarker Tests May Detect Cancer Earlier Than DNA-Based Methods

Disease States

Study Finds Multi-Omic Breast Cancer Test Predicts Radiation Therapy Benefit

Data show the test can predict both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer.

Disease States

Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses

The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.

Cancer

FDA Grants Breakthrough Status to Breath Test for Postoperative Pneumonia Risk

The FDA has granted Breakthrough Device Designation to Breath Diagnostics Inc.'s OneBreath, a breath-based test that assesses postoperative pneumonia risk in cardiac surgery patients using a single preoperative sample.

Infectious Diseases

CDC Selects Cepheid as National Collaborator for Rapid Diagnostic Development

The CDC has named Cepheid one of four national collaborators to accelerate rapid diagnostic assay development for public health emergencies under a new federal initiative and IDIQ contract.

Womens Health

Blood Test for Endometriosis Detection Now Available at IVF Centers

HerAnova Lifesciences has launched HerResolve, the first blood-based test for endometriosis detection, at IVF centers nationwide. Validation studies show diagnostic accuracy comparable to surgical standards, according to the company.

Allergy & Autoimmune

Skin Patch Opens New Door for Immune Monitoring

Researchers at JAX and MIT have developed a microneedle patch that samples immune cells from skin within hours, providing a noninvasive alternative to blood draws and biopsies.

Cardiovascular, Cerebrovascular

New Urine Test Offers Faster, Cheaper Diagnosis for Inherited Nerve Disorder

The test measures two sugar alcohols to detect SORD-related neuropathy, which standard genetic tests sometimes miss.

Dementias & Alzheimer’s

Lucent Diagnostics Partners to Bring Blood-Based Alzheimer’s Testing to Community Settings

The collaboration will expand access to Alzheimer's biomarker testing through mobile delivery to community centers, churches, and senior centers nationwide.

Diabetes & Metabolic Diseases

New Blood Test Score Identifies Hidden Alcohol-Related Liver Disease

Researchers at UC San Diego have developed the MAPI score, a blood test using five standard lab values to distinguish alcohol-related liver injury from metabolic causes, according to a study in Gastroenterology.

Kidney Disease

Carna Health, Siemens Healthineers Partner on AI-Enabled CKD Platform

The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

Study Finds Test Helps Distinguish Infection From Inflammation in Bone Marrow Transplant Patients

Research in bone marrow transplant patients with blood cancers and febrile neutropenia suggests the host-response test may help identify infection in high-risk populations.